Cho-Vega Jeong Hee, Medeiros L Jeffrey, Prieto Victor G, Vega Francisco
Department of Pathology, The Methodist Hospital, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Am J Clin Pathol. 2008 Jan;129(1):130-42. doi: 10.1309/WYACYWF6NGM3WBRT.
Leukemia cutis (LC) is a nonspecific term used for cutaneous manifestations of any type of leukemia. LC has a wide range of cutaneous manifestations, which can make it difficult to clinically distinguish LC from other skin lesions. Patients with LC usually have concomitant systemic leukemia, but occasionally skin involvement precedes the involvement of the bone marrow or peripheral blood. Thus, a skin biopsy can be the first indication of the presence of leukemia in a subset of patients. The immunophenotyping of routinely processed skin biopsy specimens is very useful in establishing the diagnosis of LC. Although the molecular mechanisms explaining the pathogenesis of LC are not well defined, chemokine receptors and adhesion molecules may have an important role in skin tropism. We review the literature and recent advances pertaining to LC, with special emphasis on the immunohistochemical assessment and possible mechanisms involved in skin tropism by leukemic cells.
皮肤白血病(LC)是用于描述任何类型白血病皮肤表现的一个非特异性术语。LC有广泛的皮肤表现,这使得在临床上难以将LC与其他皮肤病变区分开来。LC患者通常伴有全身性白血病,但偶尔皮肤受累先于骨髓或外周血受累。因此,皮肤活检可能是一部分患者白血病存在的首要指征。常规处理的皮肤活检标本的免疫表型分析在确立LC诊断方面非常有用。尽管解释LC发病机制的分子机制尚未明确,但趋化因子受体和黏附分子可能在皮肤嗜性中起重要作用。我们回顾了与LC相关的文献和最新进展,特别强调免疫组织化学评估以及白血病细胞皮肤嗜性可能涉及的机制。